Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. 1992

R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

We isolated a cDNA encoding type-1 angiotensin II receptor from a human liver cDNA library. The cDNA had an open reading frame encoding a protein of 359 amino acid residues with a relative Mr of 41,060. The deduced amino acid sequence of the human angiotensin II (Ang II) receptor was 95.3% and 94.2% identical to those of bovine and rat type-1 Ang II receptors, respectively, and had a significant similarity with the G protein-coupled receptor. The rank order of the binding to the receptor expressed in COS-7 cells was Ang II greater than Ang III greater than Ang I. The expression of the Ang II receptor mRNA was detected in human liver, lung, adrenal and adrenocortical adenomas but not in adrenomedullary tumor, pheochromocytoma, by Northern blot analysis.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015183 Restriction Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA. Endonuclease Mapping, Restriction,Enzyme Mapping, Restriction,Site Mapping, Restriction,Analysis, Restriction Enzyme,Enzyme Analysis, Restriction,Restriction Enzyme Analysis,Analyses, Restriction Enzyme,Endonuclease Mappings, Restriction,Enzyme Analyses, Restriction,Enzyme Mappings, Restriction,Mapping, Restriction,Mapping, Restriction Endonuclease,Mapping, Restriction Enzyme,Mapping, Restriction Site,Mappings, Restriction,Mappings, Restriction Endonuclease,Mappings, Restriction Enzyme,Mappings, Restriction Site,Restriction Endonuclease Mapping,Restriction Endonuclease Mappings,Restriction Enzyme Analyses,Restriction Enzyme Mapping,Restriction Enzyme Mappings,Restriction Mappings,Restriction Site Mapping,Restriction Site Mappings,Site Mappings, Restriction

Related Publications

R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
March 1994, Biochemical and biophysical research communications,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
May 1994, Biochemical and biophysical research communications,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
November 1994, Biochemical and biophysical research communications,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
February 1992, Biochemical and biophysical research communications,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
December 1990, Biochemical and biophysical research communications,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
May 1991, Biochemical and biophysical research communications,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
December 1989, The Journal of biological chemistry,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
May 1991, Nature,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
January 1986, Methods in enzymology,
R Takayanagi, and K Ohnaka, and Y Sakai, and R Nakao, and T Yanase, and M Haji, and T Inagami, and H Furuta, and D F Gou, and M Nakamuta
July 1992, Biochemical and biophysical research communications,
Copied contents to your clipboard!